# HCC Risk and Monitoring in Patients With Type 2 Diabetes

> **NCT07675187** · NA · NOT_YET_RECRUITING · sponsor: **National Taiwan University Hospital** · enrollment: 2400 (estimated)

## Conditions studied

- Type 2 Diabetes (T2DM)
- Hepatocellular Carcinoma (HCC)

## Interventions

- **DIAGNOSTIC_TEST:** GAAD score

## Key facts

- **NCT ID:** NCT07675187
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07-01
- **Primary completion:** 2028-12-31
- **Final completion:** 2030-12-31
- **Target enrollment:** 2400 (ESTIMATED)
- **Last updated:** 2026-07-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07675187

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07675187, "HCC Risk and Monitoring in Patients With Type 2 Diabetes". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07675187. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*